Table 3.

Symptoms, laboratory, ECG and imaging data

Symptoms (n=70), n (%)	Count
Chest pain	70 (100%)
Palpitations	14 (20.0%)
Dyspnoea	21 (30.0%)
Diaphoresis	6 (8.6%)
Non-specific symptoms (dizziness, vomiting, fatigue)	33 (47.1%)
Laboratory test	Value
Troponin (n=70), median fold increase	138.3 (IQR 56.9–315.0)
Testing/imaging	Count
ECG (n=70), n (%)
Abnormal	49 (70.0%)
Normal	21 (30.0%)
Abnormal ECG findings or arrhythmias (n=49)
ST-wave or T-wave changes/elevation	28 (57.1%)
ST segment depression in AVR	9 (18.4%)
PR depression without reciprocal ST depression	7 (14.3%)
AV node conduction delay	3 (6.1%)
T wave inversion	3 (6.1%)
Other	9 (18.4%)
Echocardiogram (n=68)
Normal function	62 (91.2%)
Abnormal function	8 (8.8%)
Systolic dysfunction	5 (62.5%)
Wall motion abnormalities	2 (25.0%)
LV strain	1 (12.5%)
Cardiac MRI (n=36)
Abnormal findings, n (%)	33 (91.7%)
Late gadolinium enhancement	32 (97.0%)
Myocardial oedema	20 (60.6%)
Other abnormality on T2 imaging	9 (27.3%)
Pericardial effusion or inflammation	5 (15.2%)
Fibrosis	2 (2.4%)

LV, Left ventricular.